Literature DB >> 11179119

Influence of donor and recipient HLA locus mismatching on development of obliterative bronchiolitis after lung transplantation.

L L Schulman1, A D Weinberg, C C McGregor, N M Suciu-Foca, S Itescu.   

Abstract

Obliterative bronchiolitis (OB) after lung transplantation is the end result of multiple immunologic, virologic, genetic, and environmental effects on the transplanted lung. In this study, we first analyzed risk factors for OB in a single-center population of 152 lung transplant recipients. We then examined the influence of donor and recipient HLA mismatching on progression to OB, and on the identified risk factors for OB. The median time to onset of OB for the entire study population was 2.7 yr. The significant risk factors for OB by multivariate analyses were grade A2 or A3 acute rejection (p = 0.0126) and cytomegalovirus (CMV) pneumonitis (p = 0.0358). The only significant HLA risk factor for OB was mismatching at the HLA-A locus (p = 0.0144). On the basis of Cox proportional hazards modeling, a predictive formula was derived to estimate the risk of OB after lung transplantation. Although mismatching at the HLA-DR locus was a significant risk factor for CMV pneumonitis in recipients exposed to CMV before transplantation (p = 0.0199), and protected against acute rejection, it did not independently protect against OB. These results indicate that HLA mismatches between donors and recipients significantly influence the development of OB both directly, and indirectly, by influencing the major risk factors for OB.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11179119     DOI: 10.1164/ajrccm.163.2.2005031

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  7 in total

Review 1.  Mechanisms of chronic rejection in cardiothoracic transplantation.

Authors:  Matthew J Weiss; Joren C Madsen; Bruce R Rosengard; James S Allan
Journal:  Front Biosci       Date:  2008-01-01

Review 2.  Bronchiolitis obliterans syndrome: risk factors and therapeutic strategies.

Authors:  Andrew I R Scott; Linda D Sharples; Susan Stewart
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Impact of MHC class II incompatibility on localization of mononuclear cell infiltrates to the bronchiolar compartment of orthotopic lung allografts.

Authors:  Shinji Nakashima; T Rinda Soong; Karen Fox-Talbot; Zhiping Qian; Salma Rahimi; Barbara A Wasowska; Charles A Rohde; Sabrina Chen; Joe G N Garcia; William M Baldwin
Journal:  Am J Transplant       Date:  2005-04       Impact factor: 8.086

4.  Spirometrically significant acute rejection increases the risk for BOS and death after lung transplantation.

Authors:  W A Davis; C A Finlen Copeland; J L Todd; L D Snyder; J A Martissa; S M Palmer
Journal:  Am J Transplant       Date:  2011-11-28       Impact factor: 8.086

5.  Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.

Authors:  Kirsten M Williams; Jason W Chien; Mark T Gladwin; Steven Z Pavletic
Journal:  JAMA       Date:  2009-07-15       Impact factor: 56.272

6.  The Prognostic Importance of Bronchoalveolar Lavage Fluid CXCL9 During Minimal Acute Rejection on the Risk of Chronic Lung Allograft Dysfunction.

Authors:  M Y Shino; S S Weigt; N Li; A Derhovanessian; D M Sayah; R Saggar; R H Huynh; A L Gregson; A Ardehali; D J Ross; J P Lynch; R M Elashoff; J A Belperio
Journal:  Am J Transplant       Date:  2017-08-02       Impact factor: 9.369

7.  Hypertabastic survival model.

Authors:  Mohammad A Tabatabai; Zoran Bursac; David K Williams; Karan P Singh
Journal:  Theor Biol Med Model       Date:  2007-10-26       Impact factor: 2.432

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.